In todays video, the CEO of STENOCARE – Thomas Skovlund Schnegelsberg – shares an update on the top-5 hightlights for STENOCARE:
- Profitable for 2019 – as one of few in the European medical cannabis industry
- Close to end of pause in sales
- Recognized as a European leader by leading industry analysts
- Planning to expand into more European markets
- Looking for investment and acquisition opportunities in the industry
The video is available on the STENOCARE website: